NanoViricides Inc. (NNVC)

[crashco]

Nanoviricides has stated all along that viricides were novel. They explored contracting manufacture. Executive leadership opted to build the first generation plant themselves when conditions for contracting did not serve the best interest of the company and shareholders. You are taking my comments out of context. NanoViricides and any long term investor who has paid attention knew that manufacture of viricides would be proprietary. You claim, or more accurately since you tend to speak obliquely, insinuate that there was a radical change in manufacturing plan and principles within the past year. I contend that this is untrue. You accuse management of misleading shareholders. Since manufacturing principles have not changed you charge is without merit. Formulas have evolved and improved. Concepts of manufacturing have remained consistent. Understandable challenges associated with scaling up were anticipated, were communicated, and have been overcome to date.